Pradžia › Narkolepsija › Texas
Narkolepsija klinikiniai tyrimai Texas
6 tyrimai dėl Narkolepsija ieško dalyvių vietose Texas.
Miestai Texas
Oficialus tyrimo tekstas (anglų kalba)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Austin, Texas, Austin
- Dallas, Texas, Dallas
- Houston, Texas, Houston
- ir dar 2
Renkami dalyviai2/3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07598708A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Austin
- Alkermes Investigational Site, San Antonio
- Alkermes Investigational Site, Sugar Land
Renkami dalyviai3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07455383A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Aayus Research, Austin
- Southwest Family Medicine, Dallas
- Metroplex Pulmonary and Sleep Center, McKinney
- ir dar 3
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-27 · NCT07675135A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Austin
- Alkermes Investigational Site, San Antonio
- Alkermes Investigational Site, Sugar Land
Renkami dalyviai2/3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-08-07 · NCT06767683A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
- Future Search Trials of Neurology, Austin
- Sleep Therapy and Research Center, San Antonio
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-14 · NCT07493265A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Austin, Texas, Austin
- El Paso, Texas, El Paso
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-04-16 · NCT07096674Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.